Skip to content

Clinical trials

Observational Nervous System Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Phase: Observational Country / region: United States Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20062
20081
20103
20112
20124
20133
20145
20157
20161
20172
20189
20197
20203
20219
20225
20231
20247
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Recruiting23
Terminated4
Enrolling by invitation3
Unknown status3
Active, not recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)14
National Institute of Mental Health (NIMH)5
Vanderbilt University Medical Center4
Boston Children's Hospital3
Epilepsy Foundation of America2
Massachusetts General Hospital2
Myomo2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Tammie L. S. Benzinger, MD, PhD2
Washington University School of Medicine2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases87
Central Nervous System Diseases13
Brain Diseases12
Neurodegenerative Diseases11
Alzheimer Disease9
Epilepsy8
Neurologic Manifestations8
Dementia7
Genetic Diseases, Inborn7
Movement Disorders7

Trials

Showing 1 to 25 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.